NEWDIGS Members and Collaboration Partners
Alliance for Regenerative Medicine
Avalere
Beth Israel Deaconess Medical Center (BIDMC)
Bill & Melinda Gates Foundation
Blue Cross Blue Shield Association
Canadian Agency for Drugs and Technologies in Health (CADTH)
Canadian Organization for Rare Disorders (CORD)
Cerevel Therapeutics
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Organisation for Rare Diseases (EURORDIS)
European Medicines Agency (EMA)
European network for Health Technology Assessment (EUnetHTA)
Family Heart Foundation
Flatiron Health
Food and Drug Administration (FDA, USA)
Harvard-MIT Center for Regulatory Science
Harvard School of Public Health
Health Sciences Authority (HSA, Singapore)
Innovative Medicines Initiative (IMI)
Massachusetts General Hospital Cancer
Massachusetts General Hospital Rheumatology
Massachusetts Institute of Technology
Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC)
Medical Products Agency (MPA, Sweden)
Medicines and Healthcare products Regulatory Agency (MHRA)
National Healthcare Institute (ZIN, the Netherlands)
National Hemophilia Foundation
National Institute for Health and Care Excellence (NICE)
National Organization for Rare Disorders (NORD)
National Pharmaceutical Council (NPC)
Scipher Medicine
Sequoia Reinsurance Services
Takeda
Tufts Clinical and Translational Science Institute
Tufts Medical Center Institute for Clinical Research and Health Policy Studies
University of Southern California
Vertex Pharmaceuticals
Consortium Members in bold.